Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Clinical trial NCT05804045 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05804045
Sponsor: Abbisko Therapeutics Co, Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Tenosynovial Giant Cell Tumor Pigmented Villonodular Synovitis Giant Cell Tumor of Tendon Sheath

Start date: 2023-04-27
Primary completion: 2024-09-23
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.